UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2016 | 2016-11-14 | Future report Set alerts | |
| Q2 2016 | 2016-08-11 | Future report Set alerts | |
| Q1 2016 | 2016-05-10 | -0.16 | -0.16 |
| Q4 2015 | 2016-03-21 | -0.13 | -0.13 |
| Q3 2015 | 2015-11-12 | -0.15 | -0.15 |
| Q2 2015 | 2015-08-11 | -0.15 | -0.15 |
| Q1 2015 | 2015-05-07 | -0.14 | -0.14 |
| Q4 2014 | 2015-03-17 | -0.07 | -0.07 |
| Q3 2014 | 2014-11-13 | -0.21 | -0.21 |
| Q2 2014 | 2014-08-07 | -0.18 | -0.18 |
| 2016-06-01 | Downgrade | Janney Montgomery Scott | Buy to Neutral | |
| 2016-06-01 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2016-05-31 | Downgrade | Needham & Company LLC | Buy to Hold | |
| 2016-05-31 | Downgrade | Roth Capital | Buy to Neutral | $30.25 to $26.00 |
| 2016-05-19 | Reiterated Rating | Roth Capital | Buy | $22.00 to $26.00 |
| 2016-04-22 | Initiated Coverage | Stifel Nicolaus | Buy | $23.00 |
| 2016-04-12 | Reiterated Rating | Roth Capital | Buy | $22.00 |
| 2016-04-12 | Initiated Coverage | Needham & Company LLC | Buy | $24.00 |
| 2016-03-22 | Reiterated Rating | Roth Capital | Buy | $22.00 |
| 2016-03-15 | Boost Price Target | Roth Capital | Buy | $18.00 to $22.00 |
| 2016-03-15 | Boost Price Target | HC Wainwright | Buy | $20.00 |
| 2016-03-15 | Initiated Coverage | Janney Montgomery Scott | Buy | $13.00 |
| 2015-10-30 | Reiterated Rating | FBR & Co. | Outperform | |
| 2015-10-30 | Reiterated Rating | FBR & Co | Outperform | |
| 2015-09-25 | Reiterated Rating | Roth Capital | Buy | |
| 2015-08-12 | Reiterated Rating | MLV & Co. | Buy | $6.00 |
| 2015-07-27 | Boost Price Target | Roth Capital | Buy | $15.00 to $18.00 |
| 2015-07-17 | Reiterated Rating | Roth Capital | Buy | $15.00 |
| 2015-06-26 | Initiated Coverage | MLV & Co. | Buy | |
| 2015-06-26 | Reiterated Rating | Roth Capital | Buy | $15.00 |
| 2015-06-26 | Reiterated Rating | HC Wainwright | Buy | |
| 2015-06-19 | Initiated Coverage | MLV & Co. | Buy | $6.00 |
| 2015-06-08 | Reiterated Rating | Roth Capital | Buy | $15.00 |
| 2014-09-05 | Initiated Coverage | HC Wainwright | Buy | $7.00 |
| 2016-06-01 | Downgrade | Janney Montgomery Scott | Buy to Neutral | |
| 2016-06-01 | Downgrade | Stifel Nicolaus | Buy to Hold | |
| 2016-05-31 | Downgrade | Needham & Company LLC | Buy to Hold | |
| 2016-05-31 | Downgrade | Roth Capital | Buy to Neutral | $30.25 to $26.00 |
| 2016-05-19 | Reiterated Rating | Roth Capital | Buy | $22.00 to $26.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In CPXX 1 funds of 2197 total. Show all
| Fund name | Ticker shares |
|---|---|
| RUSSELL FRANK CO/ | 0.12M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| VENTURES WEST CAPITAL LTD | 8.23% (2146372) | CPXX / |
| QUAKER BIO VENTURES LP | 2.26% (590427) | CPXX / OCRX / RGDO / |
Undercovermarket.com